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Abstract
Introduction
The  high  prevalence  of  cardiovascular  disease  (CVD) 
in the Hispanic population of the United States, together 
with  low  rates  of  health  insurance  coverage,  suggest  a 
potential  cardiovascular  health  crisis.  The  objective  of 
Project HEART (Health Education Awareness Research 
Team) was to promote behavior changes to decrease CVD 
risk factors in a high-risk Hispanic border population.
Methods
Project HEART took place from 2005 through 2008 as 
a randomized community trial with a community-based 
participatory  research  framework  using  promotores  de 
salud  (community  health  workers).  A  total  of  328  par-
ticipants with at least 1 CVD risk factor were selected by 
randomizing 10 US Census tracts in El Paso, Texas, to 
either the experimental or the control group. The experi-
mental group (n = 192) was assigned to a series of 8 health 
classes using the Su Corazón, Su Vida curriculum. After 
2 months of educational sessions, the group was followed 
for 2 months. The control group (n = 136) was given basic 
educational materials at baseline, and no other interven-
tion was used. Main outcomes of interest included changes 
in health behaviors and clinical measures.
Results
Participants  in  the  experimental  group  showed  more 
awareness of CVD risk factors, more confidence in the con-
trol of these factors, and improved dietary habits (ie, lower 
salt and cholesterol intake, better weight control practices) 
compared with the control group. Total cholesterol was 3% 
lower in the experimental than in the control participants, 
and  non–high-density  lipoprotein  cholesterol  and  low- 
density lipoprotein cholesterol were both 5% lower.
Conclusion
The HEART trial suggests that community health edu-
cation using promotores de salud is a viable strategy for 
CVD risk reduction in a Hispanic border community.
Introduction
Heart disease and stroke are the leading causes of death 
among Hispanics, including those of Mexican origin (1,2). 
The “Hispanic paradox” is that morbidity and mortality for 
chronic diseases such as cardiovascular disease (CVD) are 
lower than for other racial and ethnic groups, despite the 
low socioeconomic status of the Hispanic population (3). 
Evidence against this paradox, however, has been grow-
ing. Some epidemiologic reports suggest that CVD mortal-
ity for Hispanics, the largest and fastest-growing minority 
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population in the United States (4), are equal to and in 
some instances higher than for non-Hispanic whites (5,6).
The  high  prevalence  of  CVD  risk  factors  among 
Hispanics,  together  with  the  lack  of  health  insurance 
coverage for screening and limited public health capacity 
for prevention and control, suggests a looming Hispanic 
cardiovascular health crisis (7). The community outreach 
model of public health using community health workers 
(promotores) has been proposed as a viable approach to 
reduce heart disease and stroke among Hispanics (8,9). 
A systematic review of US-based randomized controlled 
trials using promotores supports the use of this model for 
addressing CVD and its risk factors (10).
Few randomized controlled trials have studied the use of 
promotores to reduce CVD risk factors in the Hispanic bor-
der community. Two interventions used have shown how a 
promotora model can be integrated into community-based 
chronic disease prevention to address CVD in Hispanics 
(11,12). Secretos de la Buena Vida (Secrets of the Good Life) 
was  designed  to  improve  dietary  and  nutritional  habits 
among Spanish-speaking Hispanics/Latinos in California, 
and  Pasos  Adelante  (Steps  Forward)  adapted  the  Su 
Corazón, Su Vida (Your Heart, Your Life) curriculum of the 
Salud Para Su Corazón (Health for Your Heart) program 
(13) to reduce risk factors for CVD, diabetes, and other 
chronic  diseases  among  Arizona  Hispanics.  Salud  Para 
Su Corazón is an initiative of the National Heart, Lung, 
and  Blood  Institute  based  on  the  model  of  community-
based participatory research (CBPR) and has been used in 
other promotores interventions for CVD and its risk factors   
(13-16).
This article describes Project HEART (Health Education 
Awareness Research Team), which was based on Salud 
Para Su Corazón and used a CBPR approach to support 
the promotora model. The HEART intervention promoted 
a series of positive changes in behaviors to increase aware-
ness of the need to reduce clinical risk factors such as high 
cholesterol and high blood pressure among Hispanic par-
ticipants in a large metropolitan border population.
Methods
The CBPR agenda for HEART
Project  HEART  was  the  first  phase  (2005-2008)  of  a 
CBPR initiative and included 1) 3 academic partners: the 
University of Texas at El Paso, the University of Texas at 
Houston Health Science Center School of Public Health, El 
Paso Regional Campus, and El Paso Community College; 
2) a community clinic, Centro San Vicente, that provides 
services to residents of El Paso who do not have adequate 
health insurance coverage; 3) promotores from a network 
of partner organizations in El Paso; and 4) a community 
advisory council. Approval was obtained from both institu-
tional review boards of the University of Texas at El Paso 
and the University of Texas at Houston Health Science 
Center School of Public Health.
During the first year of the project (September 2005-
August 2006), a variety of CBPR strategies were used for 
Project  HEART  to  engage  different  constituencies  and 
partners in a dialogue about how to decrease the preva-
lence of CVD risk factors in Hispanics (most of Mexican 
origin) who live in El Paso, Texas. They included a pro-
motora community forum, focus groups, and a community 
advisory council. Information about these activities can be 
obtained from the first author (HB).
Development of promotora training
Promotores from the network of partner organizations 
were trained for 1 week with the Su Corazón, Su Vida cur-
riculum. This curriculum has been used in several of the 
Salud Para Su Corazón promotora community interven-
tions (13-16). Twenty promotores participated in approxi-
mately 16 to 18 hours of training to complete Su Corazón, 
Su Vida lessons taught by a lead promotora from Centro 
San Vicente clinic. From the 20 promotores, 3 were hired 
by the clinic to participate in the 4-month project.
Recruitment
Recruitment of participants for the 4-month interven-
tion started in the fall of 2006. Ten US Census tracts in 
the 79915 zip code (area of the Lower Valley of El Paso 
selected  by  the  community  advisory  council)  were  ran-
domly assigned to either the experimental or the control 
group. The Lower Valley area is characterized by a larger 
percentage  of  residents  of  Hispanic  descent  (94%)  and 
lower mean educational attainment than the rest of El 
Paso. Only approximately 5% of residents have an educa-
tion beyond high school, the median annual family income 
is approximately $26,000, and approximately 26% of fami-
lies live below the federal poverty threshold (17).VOLUME 7: NO. 2
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Blocks within each census tract were assigned to recruit-
ers  (graduate  students  and  employees  of  Centro  San 
Vicente  clinic),  who  were  unaware  whether  the  census 
tract was assigned to the experimental or control group. 
Using  a  screening  instrument  designed  for  the  project 
(Appendix), recruiters visited 3,959 households to deter-
mine whether their inhabitants qualified for the study. To 
qualify for the study, participants had to be aged 30 to 75 
years and have at least 1 self-reported risk factor for CVD 
(smoking, overweight or obese, diabetes, hypertension, or 
high cholesterol). Exclusion criteria were pregnancy, hav-
ing a history of CVD, or not planning to stay in El Paso 
for the remainder of the study. For people who met the 
inclusion criteria, the study was explained and informed 
consent was sought. Only 1 participant per household was 
selected. The intervention phase took place from the fall of 
2006 through the spring of 2007.
Intervention design
The experimental group was assigned to a series of 8 
health classes using the Su Corazón, Su Vida curriculum 
conducted by promotores. Each class lasted approximately 
2  hours  and  was  delivered  every  week  for  2  months. 
Participants were then followed for 2 months. Follow-up 
consisted of 3 telephone calls and a small group session at 
Centro San Vicente clinic guided by the promotores to dis-
cuss changes made as a result of the Su Corazón, Su Vida 
classes  and  to  encourage  further  changes.  The  control 
participants were given the basic educational materials 
from the curriculum in person at the time of the baseline 
assessment. No promotora involvement was provided to 
the control group.
Baseline and postintervention assessments
Height,  weight,  waist  circumference,  blood  pressure, 
hemoglobin A1c (HbA1c), and lipids were measured for all 
participants at baseline and 4 months after the intervention. 
Body mass index, metabolic syndrome, and Framingham 
10-year  CVD  risk  factor  scores  were  also  calculated  by 
using  standard  protocols  (18,19).  Prehypertension  and 
hypertension prevalence estimates were calculated accord-
ing to accepted standards from the blood pressure data 
obtained from participants (20). The questionnaire used 
validated behavioral measures from previous Salud Para 
Su  Corazón  promotora  interventions  (13-16).  The  ques-
tions assessed 1) perceived susceptibility (feeling that CVD   
risk factors put them at risk; 3 questions), 2) perceived 
severity (feeling that CVD is a serious condition; 4 ques-
tions),  3)  perceived  benefits  (benefits  of  behaviors  that 
will help them control CVD risk factors; 7 questions), 4) 
self-efficacy  (confidence  in  their  ability  to  perform  cer-
tain behaviors to control CVD risk factors; 6 questions). 
Responses were measured on a Likert-type scale of 1 to 4 
(strongly disagree to strongly agree or not at all confident 
to very confident for self-efficacy). Demographic character-
istics and medication use also were assessed.
Finally, the My Habits Scale previously tested in several 
Salud Para Su Corazón models (13-16) was used to assess 
participants’ heart-healthy behaviors associated with salt 
consumption (9 items), cholesterol and fat consumption (7 
items), and weight control (7 items). These subscales have 
shown  acceptable  reliabilities  (Cronbach  α  coefficients   
>0.70) in similar promotora studies (13,15).
Statistical analyses
Differences between baseline demographic variables for 
the experimental and control groups were tested by using 
χ2 tests for frequencies or independent-samples t test for 
continuous  variables.  Unadjusted  values  for  between-
group differences before and after the intervention were 
obtained by using paired-samples t tests. Between-groups 
analysis of covariance was used to evaluate postinterven-
tion results, adjusting for baseline values and covariates 
that  were  significant  between  groups  at  baseline.  An 
intent-to-treat analysis was used for all comparisons.
Results
Of the 1,395 people who were asked about their willing-
ness to answer the screening questions, 993 (71%) agreed. 
Of these, 568 were eligible for the study and 407 (71%) 
agreed to participate. Of the 407 who agreed to participate, 
328 (81%) were measured at baseline (192 in the experi-
mental group and 136 in the control group) and 284 were 
measured at follow-up (158 in the experimental group and 
126 in the control group), a retention rate of 87%.
Unadjusted findings
At baseline, more than 70% of participants were female, 
and the mean age was 54 years (Table 1). More than 90% of 
participants spoke Spanish or were bilingual, and approxi-
mately 40% reported having no health insurance. More VOLUME 7: NO. 2
MARCH 2010
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than half of the participants were born in Mexico (53%). 
Participants had lived in the United States an average 
of 39 years. Almost 50% of both experimental and control 
groups reported a family history of CVD, and more than 
65% reported a family history of diabetes. Place of birth, 
years  lived  in  the  United  States,  language,  educational 
attainment, and self-reported financial status were differ-
ent between experimental and control groups at baseline. 
However,  except  for  blood  pressure,  the  groups  did  not 
differ on clinical indicators at baseline (data not shown). 
Fifty-one  percent  of  participants  in  the  experimental 
group  attended  all  8  classes.  Sixty  percent  attended  at 
least 4 classes.
For the experimental group, significant decreases were 
observed  at  4-month  follow-up  for  weight,  low-density 
lipoprotein (LDL) cholesterol, total cholesterol, non–high-
density lipoprotein (HDL) cholesterol, systolic blood pres-
sure, and diastolic blood pressure (Table 2). For the con-
trol  group,  significant  changes  were  observed  for  waist 
circumference (increased), HbA1c (increased), and systolic 
and diastolic blood pressure (decreased). For both groups, 
the risk for metabolic syndrome, based on mean number 
of  risk  factors,  increased  slightly.  The  10-year  risk  for 
CVD using the Framingham score was 5% lower for both 
groups. For the clinical indicators that were self-reported 
or  calculated,  only  diastolic  hypertension  showed  a  sig-
nificant decrease from baseline in the experimental group, 
whereas  significant  decreases  were  observed  in  systolic 
and diastolic hypertension in the control group.
Adjusted findings
Only 1 clinical indicator, diastolic blood pressure, was sig-
nificantly different between the 2 groups after controlling 
for baseline values and confounders (Table 3). Significant 
improvements were seen in self-reported behaviors such 
as  weight  control  practices,  salt  intake,  and  cholesterol 
and fat intake for the experimental group. Perceived sus-
ceptibility to CVD and perceived benefits of behaviors that 
will help participants control their CVD risk factors were 
significantly higher in the experimental group (Table 4).
Discussion
Project HEART successfully implemented the 4-month 
intervention in an underserved Hispanic community in the 
Lower Valley of El Paso, Texas. The 4-month educational 
intervention  using  promotores  showed  promising  results 
for  community  efforts  to  limit  risk  factors  for  CVD  in 
Hispanic residents of a US-Mexico border area.
The improvements in self-reported heart-healthy behav-
iors  seen  in  the  experimental  group  are  comparable  to 
the  results  of  similar  interventions  that  have  used  the 
Su Corazón, Su Vida curriculum of the Salud Para Su 
Corazón  program  by  employing  promotores  in  different 
settings and for different Hispanic communities (14-16). 
Similar programs in Arizona and California using promo-
tores  have  demonstrated  positive  lifestyle  and  nutrition 
changes among study participants (11-13,21).
To  our  knowledge,  this  is  the  first  randomized  com-
munity  trial  using  promotores  in  a  Hispanic  border   
community to evaluate clinical outcomes for CVD risk fac-
tors. Elsewhere we have provided empiric evidence that 
Hispanic border populations tend to have a family history 
of CVD and diabetes, low perceived knowledge and self-
efficacy, poor dietary habits, and a high prevalence of CVD 
risk factors (22).
In  examining  unadjusted  and  adjusted  differences  in 
clinical  indicators  after  the  intervention,  and  taking 
into consideration the demographic characteristics of the 
sample participants, several trends emerged. First, some 
effects, particularly on blood pressure, were seen regard-
less of the group assignment. However, on the basis of 
unadjusted results, the experimental group had more risk 
reduction  than  the  control  group  for  many  of  the  clini-
cal indicators. Second, the unadjusted paired-test values 
suggest a positive trend for the effects of the promotora 
intervention on program participants exposed to the edu-
cational intervention. For example, total cholesterol, non-
HDL cholesterol, and LDL cholesterol decreased by 3%, 
5%, and 5%, respectively, for the experimental group.
Thus, although participation in the 4-month education 
component  improved  nutrition  behaviors  and  aware-
ness of CVD risk factors, both experimental and control 
groups showed some positive changes in clinical indica-
tors. Several explanations are possible. Changes in dietary 
intake and behavior may have occurred, but the study was 
not long enough for the changed behavior to be reflected in 
differences in clinical indicators between the 2 groups. In 
addition, self-reported intake and awareness may not be 
as strongly associated with measured clinical indicators 
as expected.VOLUME 7: NO. 2
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This study has several limitations. It was conceptual-
ized as part of a CBPR effort among several community 
and  university  partners,  and  these  partners  wanted  to 
provide  clinical  results  to  all  participants  regardless  of 
group assignment. Both groups received feedback from the 
study’s principal and co-principal investigators (LS, HB) at 
baseline, which was a powerful incentive for participants 
regardless of group assignment. Thus, receiving baseline 
measurements and interacting with the project staff may 
have been an intervention in itself.
The  study  randomized  participants  into  intervention 
and control groups, and this strategy worked well for age, 
sex, marital status, income, health insurance status, and 
family history of CVD. Despite randomization, however, 
some differences in demographic variables were present at 
baseline. To be conservative in our estimates, the variables 
that differed between groups at baseline were included as 
covariates. As a result, the power of the intervention may 
have been reduced, limiting the ability to find differences 
in clinical indicators.
The  results  of  this  randomized  community  trial  sug-
gest that community health education using promotores 
is a promising strategy to support the expansion of the 
community  outreach  model.  Integrating  this  model  in 
clinical settings may help reduce the prevalence of CVD 
risk factors in the Hispanic community. We have recently 
provided several recommendations based on an initiative 
of Salud Para Su Corazón and the Health Resources and 
Services Administration that we consider important for 
the implementation of future CBPR studies of CVD (16). 
These are 1) include support groups to monitor changes in 
clinical indicators and to encourage maintaining positive 
lifestyle changes made as a result of the intervention; 2) 
provide a visual representation of clinical measures, such 
as a graph, to motivate participants; 3) develop a referral, 
follow-up, and documentation system in clinical settings 
and integrate this system with promotores (13); 4) extend 
the intervention and evaluation timelines to at least 12 
months; and 5) provide ongoing training to program coor-
dinators  and  promotores  to  foster  sustainability  of  the 
intervention by engaging participants in CVD risk reduc-
tion  activities  at  the  community  level.  Project  HEART 
Phase  2  (2008-2013)  is  expanding  its  reach  by  using 
promotores  in  collaboration  with  parks  and  recreation 
departments, local YWCAs, community clinics, and other 
community partners.
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Tables
Table 1. Characteristics of Participants in Project HEART, El Paso, Texas, 2005-2008
Characteristica Control Group (n = 136)b Experimental Group (n = 192)b P Valuec
Female sex 90 (68) 18 (7) .20
Age, mean (SD), y .0 (1.2) . (1.) .8
Birthplace
Mexico 61 (8) 112 (60) .0
United States 66 (2) 7 (0)
Years of residence in United States, mean (SD) 1.6 (18.6) 7.1 (18.7) .0
Language spoken for survey
English only 8 (6)  (2)
.02 Spanish only  (26) 76 (0)
Both English and Spanish 90 (67) 10 (8)
Years of educational attainment, mean (SD) 10.7 (.) 9.7 (.) .01
Employed 7 () 8 (0) .
Self-reported financial status
Very well off or well off 19 (1) 12 (6)
.02 Getting by 86 (6) 11 (61)
Not getting by 0 (22) 61 (2)
Annual family income
<$10,000 0 (8) 71 (8)
.91 $10,000 to <$20,000 8 () 68 (7)
≥$20,000 7 (27) 7 (2)
No health insurance 2 (9) 8 () .28
Receive food stamps/welfare 0 (22) 8 (0) .09
Family history of CVD 9 () 91 (1) .
Family history of diabetes 87 (67) 121 (67) .2
Marital status
Married/living with a partner 92 (68) 119 (6)
.7 Widowed/separated/divorced  (2) 8 (26)
Never married 10 (7) 21 (11)
No. of people in household, mean (SD) . (1.6) . (1.8) .
 
Abbreviations: HEART, Health Education Awareness Research Team; SD, standard deviation; CVD, cardiovascular disease. 
a All values are reported as no. (%) unless otherwise indicated. 
b Values for each question may not correspond to the group total because of missing responses. Percentages may not total 100 because of rounding. 
c P values were calculating by using χ2 test (frequencies) or independent-samples t tests (continuous). Frequencies may not add up to group total for experi-
mental or control group because of missing responses.VOLUME 7: NO. 2
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Table 2. Unadjusted Differences From Baseline to Follow-Up for Cardiovascular Disease Clinical Indicators, Project HEART, El 
Paso, Texas, 2005-2008
Clinical Indicator
Control Group (n = 136)
P Valuea
Experimental Group (n = 192)
P Valuea Baseline
4-Month Follow-
Up Baseline
4-Month Follow-
Up
Mean (SD)
Body mass index, kg/m2 1.1 (6.) 1.2 (6.) .28 1.7 (6.8) 1.6 (6.7) .
Weight, lb 18.1 (2.) 18.0 (.0) .8 181.8 (9.1) 180. (0.0) .01
Waist circumference, in 0.2 (6.0) 1.0 (.7) .01 0.6 (.8) 0.7 (.9) .9
Framingham risk scoreb 1. (11.9) 9. (7.0) <.001 1. (1.2) 10.8 (7.9) <.001
Metabolic syndrome, mean no. of risk  
factors
2. (1.) 2.6 (1.) .01 2. (1.2) 2.7 (1.2) <.001
LDL cholesterol, mg/dL 120.2 (1.9) 119.8 (.6) .86 127.6 (6.2) 121. (8.0) .01
HDL cholesterol, mg/dL 2.6 (10.7) 1. (11.2) .11 0.6 (11.2) 0.6 (10.0) .97
Total cholesterol, mg/dL 190. (8.) 190. (2.) .99 197. (8.) 192. (.) .0
Non-HDL cholesterol, mg/dL 17.9 (7.7) 18.9 (2.9) .69 1.1 (1.) 19. (.1) .01
Triglyceride level, mg/dL 19.1 (82.8) 19.2 (91.7) .98 1.7 (71.) 10.9 (77.) .21
Fasting blood glucose, mg/dL 9. (1.7) 99.8 (0.7) .09 101. (0.) 10.2 (.) .10
HbA1c, % 6. (1.) 6. (1.) .01 6.6 (1.) 6.6 (1.) .8
Systolic blood pressure, mm Hg 11. (20.) 12.6 (17.) <.001 17.2 (21.8)c 11.9 (19.2) <.001
Diastolic blood pressure, mm Hg 89. (16.) 78. (10.8) <.001 80.0 (10.9)c 77.6 (9.) .01
Prevalence, %
Smoking 0 21 .09 27 19 .07
Diabetesd 0  .0  0 .2
Systolic hypertensiond  29 .01 7 29 .11
Systolic prehypertensiond 0  .0 6 1 .2
Diastolic hypertensiond 1 16 <.001 21 10 .01
Diastolic prehypertensiond 28 2 .6 28 2 .
Taking hypertension medicatione 1 0 .78 2  .9
Taking lipid-lowering medicatione 27 29 .6 29  .28
Taking diabetes medicatione 26 22 .2 29 0 .79
 
Abbreviations: HEART, Health Education Awareness Research Team; SD, standard deviation; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HbA1c, 
hemoglobin A1c. 
a P values were calculated by using paired-samples t tests. 
b Framingham score based on age, LDL cholesterol, HDL cholesterol, smoking status, diabetes diagnosis (self-report, HbA1c >7%, or fasting glucose >126 mg/
dL). 
c Significantly different from control at baseline, P < .0. 
d Diabetes defined as HbA1c >7%, fasting blood glucose >126 mg/dL, or self-report; systolic hypertension defined as >10 mm Hg and prehypertension 
defined as >120 mm Hg; diastolic hypertension defined as >90 mm Hg and prehypertension defined as >80 mm Hg. 
e All variables regarding medication intake are self-reported.VOLUME 7: NO. 2
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Table 3. Adjusted Postintervention Differences at Follow-Up for Cardiovascular Disease Clinical Indicators, Project HEART, El 
Paso, Texas, 2005-2008
Clinical Indicator Control Group 4-Month Follow-Upa (n = 126) Experimental Group 4-Month Follow-Upa (n = 158) P Valueb
Body mass index, kg/m2 1. (6.7) 1.1 (6.) .28
Weight, lb 181.1 (.2) 180. (7.) .
Waist circumference, in 1.0 (.9) 0. (.7) .09
Framingham risk scorec 9. (6.7) 10. (7.8) .26
Metabolic syndrome, mean no. of 
risk factors
2.6 (1.2) 2.7 (1.2) .2
LDL cholesterol, mg/dL 12.0 (.8) 118.6 (7.8) .20
HDL cholesterol, mg/dL 1. (11.2) 1.6 (10.2) .98
Total cholesterol, mg/dL 19.2 (2.7) 189. (.) .16
Non-HDL cholesterol, mg/dL 12. (.) 16. (2.) .10
Triglyceride level, mg/dL 19. (9.) 1.6 (78.6) .6
Fasting blood glucose, mg/dL 102.7 (2.2) 101.9 (9.8) .80
HbA1c, % 6.6 (1.) 6. (1.) .09
Systolic blood pressure, mm Hg 10. (16.7) 12.6 (19.) .20
Diastolic blood pressure, mm Hg 7. (10.6) 79.8 (9.) <.001
 
Abbreviations: HEART, Health Education Awareness Research Team; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HbA1c, hemoglobin A1c. 
a Parenthetical values represent the standard deviations. 
b Between-groups analysis of covariance for the postintervention follow-up values were adjusted for baseline value, self-reported birthplace, language chosen 
for baseline survey, years of residence in United States, educational attainment, and financial status. 
c Framingham score based on age, LDL and HDL cholesterol levels, smoking status, diabetes diagnosis (self-report, HbA1c >7%, or fasting blood glucose >126 
mg/dL).
Table 4. Adjusted Postintervention Differences at Follow-Up for Nutrition-Related Behaviors and Health Beliefs, Project 
HEART, El Paso, Texas, 2005-2008
Behavior/Belief Indicator Control Group 4-Month Follow-Upa (n = 126) Experimental Group 4-Month Follow-Upa (n = 158) P Valueb
Weight-control practicesc 1.9 (0.6) 2.0 (0.6) .01
Salt intakec 1.8 (0.) 2.0 (0.) <.001
Cholesterol and fat intakec 1.7 (0.6) 1.9 (0.7) .01
Perceived severityd .6 (0.) .6 (0.) .
Perceived benefitsd .6 (0.) .7 (0.) .01
Perceived susceptibilityd . (0.) . (0.) .01
Self-efficacyd . (0.) . (0.) .1
 
Abbreviation: HEART, Health Education Awareness Research Team. 
a Values indicate responses on a Likert-type scale of 1 to , followed by the standard deviation in parentheses. 
b Between-groups analysis of covariance for the postintervention values were adjusted for baseline value, self-reported birthplace, language chosen for base-
line survey, years of residence in United States, educational attainment, and financial status. 
c Measured with My Habits Behavioral Self-Reported Scales (1-16) indicating never to always engaging in healthy behaviors. 
d Measured with a questionnaire indicating strongly disagree to strongly agree or not at all confident to very confident for self-efficacy. VOLUME 7: NO. 2
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1.  Do you plan to move out of town in the next 6 months? 
□ Yes  
□ No  
□ Don’t know  
□ Refused 
 
2.  What is your age? 
 
.  Are you pregnant or plan to become pregnant in the next 6 months? 
□ Yes  
□ No  
□ Don’t know  
□ Refused 
 
.  Are you Hispanic or Latino? 
□ Yes  
□ No  
□ Don’t know  
□ Refused 
 
.  Have you ever been told by a doctor that you have any of the following 
risk factors? 
A. High blood pressure 
□ Yes  
□ No  
□ Don’t know
B. High cholesterol 
□ Yes  
□ No  
□ Don’t know
C. Diabetes 
□ Yes  
□ No  
□ Don’t know
D. Overweight 
□ Yes  
□ No  
□ Don’t know 
 
6.  Do you smoke cigarettes? 
□ Yes  
□ No  
 
7.  Do you have a history of heart disease? 
□ Yes  
□ No  
□ Don’t know
Checklist for eligibility:
Answers: 1. No, 2. 35 years or older, 3. No, 4. Yes, 5. and 6. At least one 
yes, 7. No
If all 1-7 answers check with eligibility criteria they are eligible: “You are 
eligible to participate in the HEART study. I will now read to you the con-
sent form and if you decide to participate, we will schedule an appoint-
ment for another interview and blood tests.”
Appendix. Screening Questionnaire for Establishing Eligibility, Project HEART (Health 
Education Awareness Research Team), El Paso, Texas, 2005-2008